ICH Trial Update-The MIND Trial

Video Transcription

Video Summary

The video is a presentation on the MIND trial, which is a multi-center study of the Artemis device for the removal of intracerebral hemorrhages (ICH). The presenter, who is one of the principal investigators for the trial, explains that ICH is a common and often devastating type of stroke, and the current standard of care is supportive treatment. The MIND trial aims to determine if minimally invasive clot removal using the Artemis device can improve outcomes for patients with ICH. The trial is a randomized controlled study involving 500 patients at up to 50 sites. The primary objective is to compare the safety and efficacy of the device with best medical management. The presenter also discusses the inclusion and exclusion criteria for the trial, as well as the assessment schedule and endpoints. Additionally, the presenter shares some data from a retrospective analysis of their own experience with the procedure, which showed a potential benefit in terms of lower mortality rates. The presentation concludes with a Q&A session.

Asset Subtitle

Adam S. Arthur, MD, MPH, FAANS, FACS

Keywords

MIND trial

Artemis device

intracerebral hemorrhages

stroke

minimally invasive clot removal

randomized controlled study